The lung cancer multidisciplinary team (MDT) is critical to best practice and better outcomes in patients with stage lll non-small cell lung cancer (NSCLC). However, according to a review article in the Asia-Pacific Journal of Clinical Oncology, only about half of patients are receiving this level of care in Australia. “Patients with stage III NSCLC ...
MDT critical to best outcomes in stage lll NSCLC
By Mardi Chapman
21 Mar 2019